SomaLogic
Latest round
- Series A
Last raised
- Jan 2021
Total raised
- $469M
Investors
- 35
About SomaLogic
, based in the US, is a clinical proteomics company focused on advanced protein measurement technologies to support healthcare and life sciences applications. SomaLogic, Inc. specializes in proteomics, providing innovative assays for protein analysis. Founded in 2000 by Larry Gold and David Brunel, and headquartered in Boulder, Colorado. In June 2025, Illumina, Inc. acquired SomaLogic, Inc., Inc. offers the SomaScan Assay Services, a proprietary proteomics platform capable of measuring 11,000 proteins from just 55-µL of sample. Utilized in a CLIA-certified and CAP-accredited lab, the platform serves clients across North America, Europe, and Asia-Pacific, including academic medical centers and pharmaceutical companies, facilitating high-throughput protein profiling for various applications in health and disease research. SomaLogic generates revenue through proteomics assay services, licensing of its SomaScan® technology, and collaborations with pharmaceutical and biotech companies. It also earns from product sales of its SOMAmer reagents and contract research services. Following its acquisition by Illumina in June 2025, SomaLogic is positioned to play a central role in advancing multiomics by integrating its proteomics technology with Illumina’s next-generation sequencing (NGS) platforms. The combined capabilities aim to reduce the cost and time of proteomic research, expand into clinical diagnostics, and accelerate biomarker discovery.
Who invested in SomaLogic
35 investors across 9 rounds
See all investors in SomaLogic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 5, 2021
Amount
$109M
Investors
Series A
Nov 20, 2020
Amount
$103M
Investors
Series A
Jul 13, 2016
Amount
$163M
Investors
Series A
Nov 9, 2010
Amount
$15M
Investors
Series A
Mar 10, 2008
Amount
$35M
Investors
Series D
Nov 13, 2003
Amount
$5M
Investors
Series C
Feb 20, 2003
Amount
$12M
Investors
Series C
Jul 5, 2002
Amount
$8M
Investors
Series B
Nov 9, 2000
Amount
$20M
Investors
Questions about SomaLogic
Who invested in SomaLogic?
SomaLogic has 35 investors on record across 9 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SomaLogic raised?
SomaLogic has raised 9 venture rounds. Sign up free to see how much each round raised and the total.
When did SomaLogic last raise money?
SomaLogic's most recent round on record is a Series A, in Jan 2021.
What does SomaLogic do?
, based in the US, is a clinical proteomics company focused on advanced protein measurement technologies to support healthcare and life sciences applications.
Where is SomaLogic headquartered?
SomaLogic is headquartered in Boulder, US.
Which VCs invest in companies like SomaLogic?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SomaLogic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SomaLogic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.